Invention Grant
US08318489B2 Prostacyclin directed differentiation of cardiomyocytes from human embryonic stem cells
有权
前列环素导向心肌细胞与人类胚胎干细胞的分化
- Patent Title: Prostacyclin directed differentiation of cardiomyocytes from human embryonic stem cells
- Patent Title (中): 前列环素导向心肌细胞与人类胚胎干细胞的分化
-
Application No.: US12158521Application Date: 2006-12-22
-
Publication No.: US08318489B2Publication Date: 2012-11-27
- Inventor: Bruce Paul Davidson , Ralph Eberhard Graichen , Robert Zweigerdt , Xiuqin Xu , Christine Lindsay Mummery , William Sun
- Applicant: Bruce Paul Davidson , Ralph Eberhard Graichen , Robert Zweigerdt , Xiuqin Xu , Christine Lindsay Mummery , William Sun
- Agent E. Stewart Mittler
- International Application: PCT/AU2006/001969 WO 20061222
- International Announcement: WO2007/070964 WO 20070628
- Main IPC: C12N5/02
- IPC: C12N5/02
![Prostacyclin directed differentiation of cardiomyocytes from human embryonic stem cells](/abs-image/US/2012/11/27/US08318489B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to the induction of differentiation in stem cells to cardiomyocytes and factors such as prostaglandin alone or in combination with other factors including essential minerals selected from the group including transferrin and selenium, small molecules selected from the group including a p38 MAPK inhibitor such as SB203580 and protein growth factors of the FGF, IGF and BMP families such as but not limited to IGF1, FGF2, BMP2, BMP4 and BMP6. and insulin that influence the process of differentiation to cardiomyocytes. Media that is appropriate for the induction of differentiation of cardiomyocytes from stem cells is also provided wherein the media contains these factors. The use of cardiomyocytes and cardiac progenitors produced by the directed differentiation in transplantation and screening for cardiac compounds is also provided.
Public/Granted literature
- US20090202498A1 DIRECT DIFFERENTIATION OF CARDIOMYOCYTES FROM HUMAN EMBRYONIC STEM CELLS Public/Granted day:2009-08-13
Information query